EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The well-developed actin cytoskeleton and Cthrc1 expression by actin-binding protein drebrin in myofibroblasts promote cardiac and hepatic fibrosis

Takanori Hironaka, Noburo Takizawa, Yuto Yamauchi, Yuma Horii, Michio Nakaya

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.102934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Takanori Hironaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Disease Control, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Actin Cytoskeleton, Myofibroblasts, Fibrosis, Extracellular Matrix Proteins. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mochida Memorial Foundation for Medical and Pharmaceutical Research, Japan Science and Technology Agency, Hoansha Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is mainly triggered by inflammation in various tissues, such as heart and liver tissues, and eventually leads to their subsequent dysfunction. Fibrosis is characterized by the excessive accumulation of extracellular matrix proteins (e.g., collagens) produced by myofibroblasts. The well-developed actin cytoskeleton of myofibroblasts, one of the main features differentiating them from resident fibroblasts in tissues under inflammatory conditions, contributes to maintaining their ability to produce excessive extracellular matrix proteins. However, the molecular mechanisms via which the actin cytoskeleton promotes the production of fibrosis-related genes in myofibroblasts remain unclear. In this study, we found, via single-cell analysis, that developmentally regulated brain protein (drebrin), an actin-binding protein, was specifically expressed in cardiac myofibroblasts with a well-developed actin cytoskeleton in fibrotic hearts. Moreover, our immunocytochemistry analysis revealed that drebrin promoted actin cytoskeleton formation and myocardin-related transcription factor-serum response factor signaling. Comprehensive single-cell analysis and RNA-Seq revealed that the expression of collagen triple helix repeat containing 1 (Cthrc1), a fibrosis-promoting secreted protein, was regulated by drebrin in cardiac myofibroblasts via myocardin-related transcription factor-serum response factor signaling. Furthermore, we observed the profibrotic effects of drebrin exerted via actin cytoskeleton formation and the Cthrc1 expression regulation by drebrin in liver myofibroblasts (hepatic stellate cells). Importantly, RNA-Seq demonstrated that drebrin expression levels increased in human fibrotic heart and liver tissues. In summary, our results indicated that the well-developed actin cytoskeleton and Cthrc1 expression due to drebrin in myofibroblasts promoted cardiac and hepatic fibrosis, suggesting that drebrin is a therapeutic target molecule for fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Actin CytoskeletonMyofibroblastsFibrosisExtracellular Matrix ProteinsNeuropeptidesHumansSingle-Cell Gene Expression AnalysisCell DifferentiationSignal TransductionHepatic Stellate CellsHeart DiseasesLiver Cirrhosis

Stichwörter der Autor:innen

actincytoskeletonfibrosishepatic stellate cell (HSC)myofibroblast

Substanzen

CTHRC1 protein, humandrebrinsExtracellular Matrix ProteinsNeuropeptides

Autor:innen und Institutionen

  • Department of Disease Control, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Disease Control, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: nakaya@phar.kyushu-u.ac.jp.

Förderung

  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Japan Science and Technology Agency
  • Hoansha Foundation
  • Nakatomi Foundation
  • Ono Medical Research Foundation
  • Senri Life Science Foundation
  • SENSHIN Medical Research Foundation
  • Kyushu University

Zitieren

APA

Hironaka, T., Takizawa, N., Yamauchi, Y., Horii, Y., & Nakaya, M. (2023). The well-developed actin cytoskeleton and Cthrc1 expression by actin-binding protein drebrin in myofibroblasts promote cardiac and hepatic fibrosis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.102934

Vancouver

Hironaka T, Takizawa N, Yamauchi Y, Horii Y, Nakaya M. The well-developed actin cytoskeleton and Cthrc1 expression by actin-binding protein drebrin in myofibroblasts promote cardiac and hepatic fibrosis. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.102934

BibTeX
@article{Hironaka2023,
  author = {Hironaka, Takanori and Takizawa, Noburo and Yamauchi, Yuto and Horii, Yuma and Nakaya, Michio},
  title = {The well-developed actin cytoskeleton and Cthrc1 expression by actin-binding protein drebrin in myofibroblasts promote cardiac and hepatic fibrosis},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.102934}
}
Kostenlos starten →